- Published
- 2021-02-03
- Venue
- Journal of Thoracic Oncology, vol. 16, no. 4, pp. 537-545
- Cited by
- 261
- Open access
- Yes, hybrid
- DOI
- 10.1016/j.jtho.2021.01.1616
- PubMed
- 33545385
Abstract
Biomarkers have various applications including disease detection, diagnosis, prognosis, prediction of response to intervention, and disease monitoring. In this era of precision medicine, having validated biomarkers to inform clinical decision making is more important than ever. In this article, we discuss best the practices and potential issues in biomarker discovery and validation. We encourage team science partnerships to bring cutting-edge discovery from bench to bedside, leading to improved patient care and outcomes.
Cite this paper
Formatted from the source metadata, not typed by hand. For a whole reference list, use the citation generator or ask your assistant through Find Research.
- APA 7
Ou, F., Michiels, S., Shyr, Y., Adjei, A. A., & Oberg, A. L. (2021). Biomarker Discovery and Validation: Statistical Considerations. Journal of Thoracic Oncology, 16(4), 537–545. https://doi.org/10.1016/j.jtho.2021.01.1616
- MLA 9
Ou, Fang‐Shu, et al. "Biomarker Discovery and Validation: Statistical Considerations." Journal of Thoracic Oncology, vol. 16, no. 4, 2021, pp. 537–545, https://doi.org/10.1016/j.jtho.2021.01.1616.
- Chicago
Ou, Fang‐Shu, Stefan Michiels, Yu Shyr, Alex A. Adjei, and Ann L. Oberg. "Biomarker Discovery and Validation: Statistical Considerations." Journal of Thoracic Oncology 16, no. 4 (2021): 537–545. https://doi.org/10.1016/j.jtho.2021.01.1616.
- GOST
Ou F., Michiels S., Shyr Y. [и др.] Biomarker Discovery and Validation: Statistical Considerations // Journal of Thoracic Oncology. — 2021. — Vol. 16, № 4. — P. 537–545. — URL: https://doi.org/10.1016/j.jtho.2021.01.1616
- BibTeX
@article{ou2021biomarker, title = {{Biomarker Discovery and Validation: Statistical Considerations}}, author = {Fang‐Shu Ou and Stefan Michiels and Yu Shyr and Alex A. Adjei and Ann L. Oberg}, journal = {Journal of Thoracic Oncology}, year = {2021}, volume = {16}, number = {4}, pages = {537--545}, doi = {10.1016/j.jtho.2021.01.1616}, url = {https://doi.org/10.1016/j.jtho.2021.01.1616} }- RIS
TY - JOUR AU - Ou, Fang‐Shu AU - Michiels, Stefan AU - Shyr, Yu AU - Adjei, Alex A. AU - Oberg, Ann L. TI - Biomarker Discovery and Validation: Statistical Considerations JO - Journal of Thoracic Oncology VL - 16 IS - 4 SP - 537 EP - 545 PY - 2021 DA - 2021/02/03 DO - 10.1016/j.jtho.2021.01.1616 UR - https://doi.org/10.1016/j.jtho.2021.01.1616 ER -